Khatereh Ahmadi

Head, Europe S&E and Oncology Lead at MSD

Dr. Khatereh Ahmadi has worked in the biotech/pharma industry for 18 years. She currently leads the Search and Evaluation Business Development team in Europe and Middle East at MSD. Previous to her role at MSD, she was a co-founder and CEO of reViral Ltd, a Phase II anti-viral company, leading a Series A round of $21M with Andera Partners and Orbimed. She played a significant role in the spin out of Piramed Ltd, an oncology company, and subsequently became head of business development culminating in a significant deal with Genentech and acquisition of Piramed by Roche. She has consulted for a number of EU and US companies in the oncology field. She obtained a PhD in biochemistry from King’s College London and held a post-doctoral position at the Ludwig Institute for Cancer Research in London working in the PI 3-kinase field. Dr. Ahmadi was awarded her MBA from Henley Management College.